Wernicke - Chief Medical Officer, Repros Therapeutics Inc

As of July 6, 2016


Wernicke Net Worth

  • Net worth is estimated to be at least $386.5K
  • Owns at least 10,000 units of Repros Therapeutics Inc stock

Wernicke Trading

  • Largest purchase of shares was 10,000 units , worth over $11.13K on January 28, 2016
  • In total has made about 2 transactions over 6 months
  • Usually trades in July and January, with the busiest year in 2016
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Wernicke Mailing Address

  • Mailing address is 2408 Timberloch Place, Suite B-7 The Woodlands TX 77380 TX

Repros Therapeutics Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Pablo Legorreta Pablo Legorreta 2020 $55,674,558 $55,674,558 $55,674,558 $55,674,558
Pablo Legorreta Pablo Legorreta 2019 $28,545,792 $28,545,792 $28,545,792 $28,545,792
Terrance Coyne Terrance Coyne 2020 $3,395,000 $3,395,000 - $3,395,000
Terrance Coyne Terrance Coyne 2019 $1,925,625 $1,925,625 - $1,925,625
Christopher Hite 2020 $3,644,711 $3,644,711 $367,788 $3,644,711
Christopher Hite 2019 - - - -
George Lloyd George Lloyd 2020 $3,395,000 $3,395,000 - $3,395,000
George Lloyd George Lloyd 2019 $2,182,500 $2,182,500 - $2,182,500
James Reddoch, Ph.D. James Reddoch, Ph.D. 2020 $3,395,000 $3,395,000 - $3,395,000
James Reddoch, Ph.D. James Reddoch, Ph.D. 2019 $2,082,500 $2,082,500 - $2,082,500
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1802768/000114036121014879/nc10022939x1_def14a.htm

Repros Therapeutics Inc Insider Trading

  • The most recent transaction was 1,064,852 units sold on September 30, 2021 by Rory B Riggs worth over $4.69M
  • In the last 5 years, insiders at Repros Therapeutics Inc sold an estimated value of $470.74M and bought an estimated value of $144.93M
  • The most active traders are George W Lloyd, EVP,  James F Reddoch, EVP,  and Katherine Anderson, CHIEF FINANCIAL OFFICER
  • Insider trading is most common in June, with the busiest year in 2021

REPROS THERAPEUTICS INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1